Anchor Capital Advisors LLC cut its position in shares of Cinemark Holdings, Inc. (NYSE:CNK) by 0.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 861,248 shares of the company’s stock after selling 6,712 shares during the quarter. Cinemark makes up about 1.3% of Anchor Capital Advisors LLC’s holdings, making the stock its 22nd biggest position. Anchor Capital Advisors LLC owned approximately 0.74% of Cinemark worth $34,622,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in CNK. Atria Investments LLC boosted its stake in Cinemark by 64.1% in the second quarter. Atria Investments LLC now owns 11,466 shares of the company’s stock valued at $402,000 after acquiring an additional 4,480 shares during the last quarter. Royal Bank of Canada boosted its stake in Cinemark by 10.4% in the first quarter. Royal Bank of Canada now owns 110,946 shares of the company’s stock valued at $4,179,000 after acquiring an additional 10,434 shares during the last quarter. Brookstone Capital Management purchased a new position in Cinemark in the second quarter valued at about $511,000. Steigerwald Gordon & Koch Inc. boosted its stake in Cinemark by 1.2% in the second quarter. Steigerwald Gordon & Koch Inc. now owns 210,529 shares of the company’s stock valued at $7,379,000 after acquiring an additional 2,472 shares during the last quarter. Finally, Strs Ohio purchased a new position in Cinemark in the second quarter valued at about $356,000. Institutional investors and hedge funds own 99.13% of the company’s stock.
NYSE CNK opened at $41.57 on Thursday. Cinemark Holdings, Inc. has a 12-month low of $32.60 and a 12-month high of $44.00. The company has a debt-to-equity ratio of 1.38, a quick ratio of 1.39 and a current ratio of 1.43. The company has a market capitalization of $4.81 billion, a PE ratio of 17.30, a price-to-earnings-growth ratio of 1.43 and a beta of 0.95.
CNK has been the topic of a number of research analyst reports. Wedbush reiterated a “buy” rating and issued a $43.00 target price on shares of Cinemark in a research note on Monday, October 15th. MKM Partners boosted their target price on shares of Cinemark to $47.00 and gave the company a “buy” rating in a research note on Wednesday, October 24th. ValuEngine upgraded shares of Cinemark from a “hold” rating to a “buy” rating in a research note on Tuesday, October 9th. Morgan Stanley dropped their target price on shares of Cinemark from $42.00 to $39.00 and set a “$34.56” rating on the stock in a research note on Monday, July 23rd. Finally, Imperial Capital initiated coverage on shares of Cinemark in a research note on Wednesday, July 11th. They issued an “outperform” rating and a $46.00 target price on the stock. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $43.25.
Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. It operates theatres in the United States, Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao, and Paraguay. As of June 30, 2018, the company operated 539 theatres and 5,998 screens.
Recommended Story: Understanding the different types of bonds
Want to see what other hedge funds are holding CNK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cinemark Holdings, Inc. (NYSE:CNK).
Receive News & Ratings for Cinemark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark and related companies with MarketBeat.com's FREE daily email newsletter.